Mexico program questions
A practical checklist for adults and families researching ibogaine programs in Mexico for alcohol treatment: ask for documentation, not reassurance.
Before travel plans or deposits, write down the answers. Compare what is said with what is documented. The broader ibogaine safety context for alcohol use disorder is a useful starting point for understanding why cardiac screening, medication review, and emergency planning matter.
01 / Medical gatekeeping
A program should be able to explain its screening process plainly and in writing. The goal is not to collect a comforting answer. It is to identify whether the program has a defined process for recognizing risks that may make ibogaine inappropriate or require medical evaluation.
Ask directly
Ask whether an ECG is required before treatment, who reviews it, what findings can delay or rule out treatment, and whether repeat monitoring is planned. Ibogaine has been associated with QT-interval concerns; the FDA’s discussion of QT prolongation and abnormal rhythms illustrates why medication and cardiac-risk review should not be treated casually.
Ask directly
Ask about electrolytes, liver-related testing, pregnancy testing where relevant, and how the program handles results that are outside its stated range. Alcohol withdrawal, dehydration, nutrition, medications, and other health conditions can complicate a decision.
Ask directly
Ask for a detailed medication and substance review rather than a generic instruction to stop everything. Do not make abrupt medication changes based on a travel program’s message alone; a clinician who knows the person’s history should be involved where possible.
Why it matters
Ask who can say no, what information that decision relies on, and whether you can receive the screening criteria in writing. A program that frames every concern as an obstacle to a “detox” is not showing a safety-first approach. For a fuller view of how this resource evaluates uncertainty, see the independent approach behind Bright Basin 88.
02 / During care
Monitoring is not a slogan. Ask how many hours ECG monitoring is used, whether it is continuous, who watches it, and what happens overnight. Ask whether staff trained in advanced cardiac life support are on site for the relevant period and how coverage changes across shifts.
The American Heart Association describes resuscitation guidelines for cardiac emergencies; a program should be able to explain its own emergency response in similarly concrete terms, without substituting vague assurances for a plan.
03 / Transparency
Written materials do not guarantee good care, but their absence is meaningful. Request the informed-consent language, screening outline, monitoring plan, emergency-transfer arrangement, and a clear description of who is responsible for each part of care.
“Can you send the consent language and monitoring plan before I decide?”
A practical first question
Ask where the ibogaine comes from, whether it is analyzed, how dosing decisions are made, and what records are kept. Ask how adverse events are defined, whether the program reviews them, and whether it will discuss them without becoming defensive.
Ibogaine is an indole alkaloid with a complex clinical history, not a standard, risk-free “reset.” Blanket language about detox, rapid cure, or guaranteed results should prompt more questions, not less.
Ask whether you can take the consent materials to a trusted clinician or family member before proceeding. If a program will not provide basic written information, treating that as a red flag is reasonable. Our safety question guides can help organize the documentation you receive without recommending a provider.
04 / Short answers
Use this checklist to slow down a decision. A prompt, polished answer can still be incomplete; a written, specific answer is more useful than a broad assurance.
No. Answers do not equate to safety. Medical governance, transparent documentation, appropriate screening, and continuity of addiction support can reduce uncertainty and risk, but cannot remove serious risk.
No ECG, no written consent, a one-person operation, blanket “detox” marketing, no emergency transfer plan, or unwillingness to discuss adverse events are reasons to step back. The ibogaine safety primer provides additional context for recognizing these gaps.
Alcohol use disorder commonly needs ongoing support. Ask what happens after discharge, who coordinates care, what relapse planning looks like, and how a local clinician or trusted support system can be involved. The National Institute on Alcohol Abuse and Alcoholism’s overview of alcohol use disorder notes that the condition can be chronic and relapsing, which is why a single intervention should not be presented as the whole plan.
Keep the standard high
Do not let urgency, travel logistics, or marketing language replace a careful review. Ask for documents. Include trusted support. Consider questions about cardiac risk, consent, emergency readiness, and continued alcohol-use-disorder care before any commitment.
Explore ibogaine abstinence safety context